Eli Lilly investors and analysts said they want to hear details from the company on how exactly it plans to grow U.S. sales ...
The EGOT winner railed against an ad that's circulating on social media with a manipulated version of her promoting "bad ...
Novo Nordisk defended its next-generation obesity drug candidate CagriSema on Wednesday following late-stage trial data ...
The drugmaker expects the regulator to remove Wegovy and Ozempic from its shortage list, blocking other companies from ...
In fact, Novo Nordisk recently reported positive results for one of its anti-obesity candidates that puts its current ...
The use of blockbuster weight loss drugs has surged among young women, for whom the treatments can often be "liberating." ...
Investors are upset at a lack of clarity over the results of Wegovy successor CagriSema after trials published in December.
Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to ...
New research suggests that Ozempic and similar weight loss medications have the potential to be as big a game changer in ...
5don MSN
A new poll from The Associated Press-NORC Center for Public Affairs Research shows about half of U.S. adults believe it is a good thing for adults to use weight-loss drugs like Ozempic, Wegovy and ...
While popular drugs like Ozempic and Wegovy are only available as injections, drugmaker Novo Nordisk is working on a more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results